This Journal of Hematology & Oncology series will focus on guidelines, consensus, and multidisciplinary approaches on cancers and blood disorders.
All submissions to this series need to be pre-approved. Prospective authors should contact the Journal Development Manager for pre-approval with the outline of their paper, the lead author name, and institution.
The deadline for submissions is 31 October 2021.
Manuscripts sponsored by pharmaceutical companies will not be considered.